The Global OTC Pharmaceutical market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. The Global OTC Pharmaceutical market is estimated at $127bn in 2016 and is dominated by the cough, cold and allergy segment which holds 23% share of the Global OTC Pharmaceutical market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 177-page report you will receive 82 tables and 79 figures – all unavailable elsewhere.
The 177-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global OTC Pharmaceutical Market forecasts from 2017-2027
• This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:
• Analgesics
• Cough, cold and allergy products
• Dermatological products
• Gastrointestinal products
• Eye Care
• Smoking Cessation Aids
• Other products
Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW
• This report provides individual revenue forecasts to 2027 for these regional and national markets:
• North America: the US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• Rest of the World: Middle East, Africa, Other Countries
• Our study provides a SWOT analysis and Porter’s Five Forces analysis of the Global OTC Pharmaceutical market
• This report discusses the leading companies in the Global OTC Pharmaceutical market
• Bayer AG
• GlaxoSmithKline (GSK) Consumer Care
• Perrigo Company PLC
• Johnson & Johnson
• Daiichi Sankyo Co., Ltd
• Pfizer Inc.
• Procter & Gamble
• Sanofi S.A
• Reckitt Benckiser Group PLC
• Cipla, Inc.
Visiongain’s study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.
Buy our report today Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 The OTC Pharmaceuticals Market Overview
1.2 Research Methodology
1.3 Global OTC Pharmaceutical Market Segmentation
1.4 Why You Should Read This Report
1.5 How this report delivers?
1.6 Key Questions Answered by This Analytical Report
1.7 Frequently Asked Questions (FAQ)
1.8 Who is This Report For?
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to OTC Pharmaceuticals
2.1 What Are OTC Pharmaceuticals?
2.2 Classification of OTC Pharmaceuticals
2.3 What are the Requirements for an OTC Pharmaceutical Drug?
2.4 OTC Switching
2.4.1 How Is a Drug Switched from Prescription to OTC?
2.5 Manufacturing and Distribution of OTC Pharmaceuticals
2.6 Regulation of OTC Pharmaceuticals
2.6.1 Regulation of OTC Pharmaceuticals in the US
2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
2.6.3 Regulation of OTC Pharmaceuticals in Europe
2.6.4 Regulation of OTC Pharmaceuticals in China
2.6.5 Regulation of OTC Pharmaceuticals in Others Countries
3. Global OTC Pharmaceutical Market Forecast 2017-2027
3.1 The Current State of the OTC Pharmaceutical Market
4. Global OTC Pharmaceutical Market by Product: Market Forecast 2017- 2027
4.1 Overview
4.2 Cough, Cold and Allergy
4.2.1 Anti-Allergy Products
4.3 Analgesics
4.3.1 Internal Analgesics
4.3.2 External Analgesics
4.4 Gastrointestinal
4.5 Dermatological
4.5.1 Minor Cuts and Wounds
4.5.2 Acne
4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema
4.5.4 Cold Sores
4.5.5 Warts
4.5.6 Fungal Skin Infections
4.5.7 Haemorrhoids
4.5.8 Other Dermatological Products
4.6 Eye Care
4.6.1 Dry Eye Syndrome
4.6.2 Bacterial Conjunctivitis
4.6.3 Ocular Allergy and Allergic Conjunctivitis
4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
4.7 Smoking Cessation Aids
4.8 Other Products
5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2017- 2027
5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2017-2027
5.2 North American OTC Pharmaceutical Market Forecasts 2017-2027
5.2.1 USA OTC Pharmaceutical Market Forecasts 2017-2027
5.2.2 Canada OTC Pharmaceutical Market Forecasts 2017-2027
5.2.3 Mexico OTC Pharmaceutical Market Forecasts 2017-2027
5.3 South American OTC Pharmaceutical Market Forecasts 2017-2027
5.3.1 Brazil OTC Pharmaceutical Market Forecasts 2017-2027
5.3.2 Argentina OTC Pharmaceutical Market Forecasts 2017-2027
5.3.3 Paraguay OTC Pharmaceutical Market Forecasts 2017-2027
5.3.4 Bolivia OTC Pharmaceutical Market Forecasts 2017-2027
5.3.5 Rest of South America OTC Pharmaceutical Market Forecasts 2017-2027
5.4 European OTC Pharmaceutical Market Forecasts 2017-2027
5.4.1 France OTC Pharmaceutical Market Forecasts 2017-2027
5.4.2 Germany OTC Pharmaceutical Market Forecasts 2017-2027
5.4.3 UK OTC Pharmaceutical Market Forecasts 2017-2027
5.4.4 Spain OTC Pharmaceutical Market Forecasts 2017-2027
5.4.5 Italy OTC Pharmaceutical Market Forecasts 2017-2027
5.4.6 Rest of Europe OTC Pharmaceutical Market Forecasts 2017-2027
5.5 Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027
5.5.1 China OTC Pharmaceutical Market Forecasts 2017-2027
5.5.2 Japan OTC Pharmaceutical Market Forecasts 2017-2027
5.5.3 India OTC Pharmaceutical Market Forecasts 2017-2027
5.5.4 Australia OTC Pharmaceutical Market Forecasts 2017-2027
5.5.5 Thailand OTC Pharmaceutical Market Forecasts 2017-2027
5.5.6 Rest of Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027
5.6 Rest of World OTC Pharmaceutical Market Forecasts 2017-2027
5.6.1 Middle East OTC Pharmaceutical Market Forecasts 2017-2027
5.6.2 Africa OTC Pharmaceutical Market Forecasts 2017-2027
5.6.3 Other Countries OTC Pharmaceutical Market Forecasts 2017-2027
6. Qualitative Analysis of the OTC Pharmaceutical Market, 2017-2027
6.1 SWOT Analysis of the OTC Pharmaceutical Market
6.2 Strengths
6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
6.2.1.1 Manufacturers Can Reap OTC Sales Benefits
6.2.1.2 Third Party Payers: Reducing the Cost Burden
6.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer
6.2.2 Many Pharmaceutical Companies Have a Strong Potential OTC Portfolio
6.2.3 Regulators Are Encouraging OTC Approvals
6.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
6.2.5 Deterring the Consumption of Counterfeit Drugs
6.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines
6.3 Weaknesses
6.3.1 Pharma Companies Remain Focused on Prescription Drugs
6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
6.3.3 OTC Products are Vulnerable to Price Controls by Governments
6.3.4 Downward Cost Pressures of OTC Drugs
6.4 Opportunities
6.4.1 Demographic and Economic Changes Will Create Growth Opportunities
6.4.2 New OTC Switch Categories
6.4.3 Strong Growth in Emerging Markets
6.4.4 New Healthcare Technologies May enable OTC Approvals
6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
6.4.6 Self-Medication Can Reduce the Under Treatment of Disease
6.5 Threats
6.5.1 Competition from Private-Label Brands Will Reduce Profitability
6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
6.6 Porter’s Five Forces Analysis of the OTC Pharmaceutical Market
6.6.1 Rivalry Among Competitors [High]
6.6.2 Threat of New Entrants [Medium]
6.6.3 Power of Suppliers [Low]
6.6.4 Power of Buyers [Medium]
6.6.5 Threats of Substitutes [Medium]
7. Leading Companies in the OTC Pharmaceutical Market
7.1 Bayer AG
7.1.1 Bayer AG: Company Overview
7.1.2 Bayer AG: Product Portfolio
7.1.3 Bayer AG: Recent Developments
7.2 GlaxoSmithKline PLC (GSK Consumer Care)
7.2.1 GlaxoSmithKline PLC: Company Overview
7.2.2 GlaxoSmithKline PLC: Product Portfolio
7.2.3 GlaxoSmithKline PLC: Recent Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson: Company Overview
7.3.2 Johnson & Johnson: Product Portfolio
7.3.3 Johnson & Johnson: Recent Developments
7.4 Perrigo Company PLC
7.4.1 Perrigo Company PLC: Company Overview
7.4.2 Perrigo Company PLC: Product Portfolio
7.4.3 Perrigo Company PLC: Recent Developments
7.5 Daiichi Sankyo Co., Ltd.
7.5.1 Daiichi Sankyo Co., Ltd.: Company Overview
7.5.2 Daiichi Sankyo Co., Ltd.: Recent Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc.: Company Overview
7.6.2 Pfizer Inc.: Product Portfolio
7.6.3 Pfizer Inc.: Recent Developments
7.7 Procter & Gamble
7.7.1 Procter & Gamble: Company Overview
7.7.2 Procter & Gamble: Product Portfolio
7.7.3 Procter & Gamble: Recent Developments
7.8 Sanofi S.A.
7.8.1 Sanofi S.A.: Company Overview
7.8.2 Sanofi S.A.: Product Portfolio
7.8.3 Sanofi S.A: Recent Developments
7.9 Reckitt Benckiser Group PLC
7.9.1 Reckitt Benckiser Group PLC: Company Overview
7.9.2 Reckitt Benckiser Group PLC: Product Portfolio
7.9.3 Reckitt Benckiser Group PLC: Recent Developments
7.10 Cipla Inc.
7.10.1 Cipla Inc.: Company Overview
7.10.2 Cipla Inc.: Product Portfolio
7.10.3 Cipla Inc.: Recent Developments
8. Conclusions
8.1 The World OTC Pharmaceutical Market in 2016-2017
8.1.1 The Leading OTC Product Categories
8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion
8.1.3 The Global OTC Market Growth Factors
8.1.4 Potential OTC Switching, 2017-2027
8.1.5 Emerging OTC Markets
8.2 Concluding Remarks
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Tables
Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2017-2027
Table 4.1 Global OTC Pharmaceutical Market Forecast, by Product ($bn, AGR%) 2017-2027
Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2017
Table 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%) 2017-2027
Table 4.4 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn, AGR%) 2017-2027
Table 4.5 OTC Internal Analgesic Active Ingredients, 2017
Table 4.6 OTC External Analgesic Active Ingredients, 2017
Table 4.7 Global OTC Pharmaceutical Market for Analgesics Market Forecast, ($bn, AGR%) 2017-2027
Table 4.8 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn, AGR%) 2017-2027
Table 4.9 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast, ($bn, AGR%) 2017-2027
Table 4.10 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography ($bn, AGR%) 2017-2027
Table 4.11 OTC Antifungal Active Ingredients, 2017
Table 4.12 Global OTC Pharmaceutical Market for Dermatological Market Forecast, ($bn, AGR%) 2017-2027
Table 4.13 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn, AGR%) 2017-2027
Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2017
Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2017
Table 4.16 OTC Ocular Allergy Active Ingredients, 2017
Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%) 2017-2027
Table 4.18 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography ($bn, AGR%) 2017-2027
Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2017
Table 4.20 Global OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%) 2017-2027
Table 4.21 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography ($bn, AGR%) 2017-2027
Table 4.22 Global OTC Pharmaceutical Market for Other Products Market Forecast, ($bn, AGR%) 2017-2027
Table 4.23 OTC Pharmaceutical Market for Other Products Market Forecast,by Geography ($bn, AGR%) 2017-2027
Table 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn, AGR%) 2017-2027
Table 5.2 North America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
Table 5.3 USA OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.6 South America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
Table 5.7 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.8 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.9 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.10 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.11 Rest of South America OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.12 European OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
Table 5.13 France OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.14 Germany OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.15 UK OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.16 Spain OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.17 Italy OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.18 Rest of European OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.19 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
Table 5.20 China OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.21 Selected Leading Companies in the Japanese OTC Pharma Market, 2017
Table 5.22 Japan OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.23 India OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.24 Australia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.25 Thailand OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.26 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.27 Rest of World OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
Table 5.28 Middle East OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.29 Africa OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 5.30 Other Countries OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
Table 7.1 Bayer AG: Company Overview
Table 7.2 Bayer AG: Product Portfolio
Table 7.4 GlaxoSmithKline PLC: Company Overview
Table 7.5 GlaxoSmithKline PLC: Product Portfolio
Table 7.6 GlaxoSmithKline PLC: Recent Developments
Table 7.7 Johnson & Johnson: Company Overview
Table 7.8 Johnson & Johnson: Product Portfolio
Table 7.9 Johnson & Johnson: Recent Developments
Table 7.10 Perrigo Company PLC: Company Overview
Table 7.11 Perrigo Company PLC: Product Portfolio
Table 7.12 Perrigo Company PLC: Recent Developments
Table7.13 Daiichi Sankyo Co., Ltd.: Company Overview
Table 7.14 Daiichi Sankyo Co., Ltd.: Recent Developments
Table 7.15 Pfizer Inc.: Company Overview
Table 7.16 Pfizer Inc.: Product Portfolio
Table 7.17 Pfizer Inc.: Recent Developments
Table 7.18 Procter & Gamble: Company Overview
Table 7.19 Procter & Gamble: Product Portfolio
Table 7.20 Procter & Gamble: Recent Developments
Table 7.21 Sanofi S.A.: Company Overview
Table 7.22 Sanofi S.A.: Product Portfolio
Table 7.23 Sanofi S.A: Recent Developments
Table 7.24 Reckitt Benckiser Group PLC: Company Overview
Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio
Table 7.26 Reckitt Benckiser Group PLC: Recent Developments
Table 7.27 Cipla Inc.: Company Overview
Table 7.28 Cipla Inc.: Product Portfolio
Table 7.29 Cipla Inc.: Recent Developments
List of Figures
Figure 1.1 OTC Pharmaceuticals: Overview of Submarkets
Figure 2.1 The OTC Pharmaceutical Supply Chain, 2017
Figure 3.1 OTC Pharmaceutical Market, by Product, ($bn), 2017-2027
Figure 3.2 OTC Pharmaceutical Market, by Geography, ($bn), 2017-2027
Figure 4.1 OTC Pharmaceutical Market, by Product, Market Share (%), 2016
Figure 4.2 OTC Pharmaceutical Market, by Product, Forecast ($bn) 2017-2027
Figure 4.3 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn) 2017-2027
Figure 4.4 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn) 2017-2027
Figure 4.5 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography, ($bn) 2017-2027
Figure 4.6 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn) 2017-2027
Figure 4.7 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography($bn) 2017-2027
Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography, ($bn) 2017-2027
Figure 4.9 OTC Pharmaceutical Market for Other Products Market Forecast, by Geography($bn) 2017-2027
Figure 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn) 2017-2027
Figure 5.2 Global OTC Pharmaceutical Market, by Geography, Market Share (%), 2016
Figure 5.3 North America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
Figure 5.4 North America OTC Pharmaceutical Market, by Country, Market Share (%), 2016
Figure 5.5 USA OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.6 Canada OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.7 Mexico OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.8 South America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
Figure 5.9 South America OTC Pharmaceutical Market, by Country, Market Share (%), 2016
Figure 5.10 Brazil OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.11 Argentina OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.12 Paraguay OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.13 Bolivia OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.14 Rest of South America OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.15 Europe OTC Pharmaceutical Market Forecast, by Country($bn) 2017-2027
Figure 5.16 Europe OTC Pharmaceutical Market, by Country, Market Share (%), 2016
Figure 5.17 France OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.18 Germany OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.19 UK OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.20 Spain OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.21 Italy OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.22 Rest of Europe OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.23 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($billion) 2017-2027
Figure 5.24 Asia-Pacific OTC Pharmaceutical Market, by Country, Market Share (%), 2016
Figure 5.25 China OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.26 Japan OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.27 India OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.28 Australia OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.29 Thailand OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.30 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.31 RoW OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
Figure 5.32 Rest of World OTC Pharmaceutical Market, by Country, Market Share (%), 2016
Figure 5.33 Middle East OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.34 Africa OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 5.35 Other Countries OTC Pharmaceutical Market Forecast ($bn) 2017-2027
Figure 6.1 Porter’s Five Analysis of the OTC Pharmaceutical Market, 2017
Figure 7.1 Bayer AG, Revenue, ($million), 2012-2016
Figure 7.2 Bayer AG, Product Segments Share (%), 2016
Figure 7.3 Bayer AG, Geographic Presence Share (%), 2016
Figure 7.4 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016
Figure 7.5 GlaxoSmithKline PLC, Product Segments Share (%), 2016
Figure 7.6 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016
Figure 7.7 Johnson & Johnson, Revenue, ($million), 2012-2016
Figure 7.8 Johnson & Johnson, Product Segments Share (%), 2016
Figure 7.9 Johnson & Johnson, Geographical Presence Share (%), 2016
Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2012-2016
Figure 7.11 Perrigo Company PLC, Product Segments Share (%), 2016
Figure 7.12 Perrigo Company PLC, Geographical Presence Share (%), 2016
Figure 7.13 Daiichi Sankyo Co., Ltd., Revenue, ($million), 2012-2016
Figure 7.14 Daiichi Sankyo Co., Ltd., Product Segments Share (%), 2016
Figure 7.15 Daiichi Sankyo Co., Ltd., Geographical Presence Share (%), 2016
Figure 7.16 Pfizer Inc., Revenue, ($million), 2012-2016
Figure 7.17 Pfizer Inc., Product Segments Share (%), 2016
Figure 7.18 Pfizer Inc., Geographical Presence Share (%), 2016
Figure 7.19 Procter & Gamble, Revenue, ($million), 2012-2016
Figure 7.20 Procter & Gamble, Product Segments Share (%), 2016
Figure 7.21 Procter & Gamble, Geographical Presence Share (%), 2016
Figure 7.22 Sanofi S.A., Revenue, ($million), 2012-2016
Figure 7.23 Sanofi S.A., Product Segments Share (%), 2016
Figure 7.24 Sanofi S.A., Geographical Presence Share (%), 2016
Figure 7.25 Reckitt Benckiser Group PLC, Revenue, ($million), 2012-2016
Figure 7.26 Reckitt Benckiser Group PLC, Product Segments Share (%), 2016
Figure 7.27 Cipla Inc., Revenue, ($million), 2012-2016
Figure 7.28 Cipla Inc., Product Segments Share (%), 2016
Figure 8.1 Global OTC Pharmaceutical Market Revenue, by Product Type ($bn), 2017-2027
Figure 8.2 Global OTC Pharmaceutical Market Revenue, by Geography ($bn), 2017-2027
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
